1 completed, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
Follow ORIOL BESTARD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Individualization of the Immunological Risk Based on Selective Biomarkers in Living-donor Renal Recipients biomarkers driven immunosuppressive therapy - Kidney Transplant Failure and Rejection | Phase 4 | Unknown | ORIOL BESTARD | 164 | 2017-11-10 | 2021-01-08 |
| Prospective, Randomized Study for Predicting Human Cytomegalovirus (hCMV) Infection Based on Baseline hCMV Specific T-cell Response in Kidney Transplant BIOMARKER- elispot test - CMV Infection, Kidney Transplantation | Phase 4 | Completed | ORIOL BESTARD | 160 | 2014-02-01 | 2018-10-03 |
Cytomegalovirus Infections (1) · Rejection, Psychology (1)
Spain (2) · Belgium (1)